Mylan NV (NASDAQ:MYL)

60.00
Delayed Data
As of Mar 30
 -1.63 / -2.64%
Today’s Change
44.74
Today|||52-Week Range
65.63
+6.44%
Year-to-Date

Today’s Trading

Previous close61.63
Today’s open58.80
Day’s range-- - --
Volume9,994,074
Average volume (3 months)3,971,229
Market cap$30.1B
Dividend yield--
Data as of 03/30/2015

Growth & Valuation

Earnings growth (last year)+48.10%
Earnings growth (this year)+16.19%
Earnings growth (next 5 years)+11.40%
Revenue growth (last year)+11.45%
P/E ratio25.9
Price/Sales2.71
Price/Book7.10

Competitors

 Today’s
change
Today’s
% change
VRTXVertex Pharmaceutica...+0.91+0.76%
ALXNAlexion Pharmaceutic...-0.33-0.18%
PRGOPerrigo Company PLC+2.29+1.38%
ZTSZoetis Inc+0.70+1.51%
Data as of 03/30/2015

Financials

Next reporting dateApril 30, 2015
EPS forecast (this quarter)$0.75
Annual revenue (last year)$7.8B
Annual profit (last year)$929.4M
Net profit margin11.97%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
Chief Executive Officer &
Executive Director
Heather M. Bresch
President &
Executive Director
Rajiv Malik
Corporate headquarters
Potters Bar, Hertfordshire

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account